CTOs on the Move

Celator Pharmaceuticals

www.celatorpharma.com

 
Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.celatorpharma.com
  • 200 PrincetonSouth Corporate Center Suite 180
    Ewing, NJ USA 08628
  • Phone: 609.243.0123

Executives

Name Title Contact Details

Funding

Celator Pharmaceuticals raised $32.5M on 08/22/2015

Similar Companies

THE KRONOS GROUP

THE KRONOS GROUP is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Delta Community Supports

Delta Community Supports is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Delta Community Supports is based in Blue Bell, PA. You can find more information on Delta Community Supports at www.deltaweb.org

Encompass Health System

Encompass Health System is a West Des Moines, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CRS Medical Technologies

CRS Medical Technologies is a New Berlin, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Questcor

We are a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Our efforts are currently focused on the fields of neurology, nephrology and rheumatology, areas of medicine which have significant unmet medical needs. Our main product is H.P Acthar® Gel (repository corticotropin injection), a naturally-derived formulation of adrenocorticotropic hormones used in a variety of disorders having an inflammatory component. We are currently supporting research in a number of rare conditions, where there is significant unmet need for treatment alternatives to standard therapies. We are also actively supporting research efforts to better understand disease processes and therapeutic mechanisms of action in conditions where Acthar might potentially play a role in treatment.